CHIRON
Live / Registered — Registered (as of 15 Apr 2025)
What this means for you
Registered since 15 Apr 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90575161
- Registration number
- 7762606
- Mark type
- Stylized text
- Filed
- 12 Mar 2021
- Published for opposition
- 23 Nov 2021
- Registered
- 15 Apr 2025
- Attorney of record
- Ashly I. Boesche
Goods and services
- Class 001 — Chemicals: Chemical preparations for use in industry; chemicals used in science; reagents for scientific purposes; diagnostic preparations, namely, antigens and antibodies for scientific purposes; testing kits for scientific purposes predominantly consisting of reagents; proteins for industrial use, namely, antigens and antibodies; nucleic acids for laboratory use, namely, nucleic acid for the production of proteins produced by biochemical and/or genetic engineering methods
- Class 005 — Pharmaceuticals: Antibacterial pharmaceuticals; diagnostic veterinary preparations; diagnostic preparations for medical purposes; diagnostic preparations, namely, antigens and antibodies for medical purposes for use in disease testing; pharmaceutical, veterinary and/or diagnostic preparations and substances produced by biochemical and/or genetic engineering methods, namely, antivirals and diagnostic preparations for veterinary and medical use; reagents for medical purposes; tests and test kits for medical and pharmaceutical purposes, namely, drug testing kits comprised of medical diagnostic reagents and assays that testing bodily fluids
- Class 040 — Treatment of materials: Custom manufacture of pharmaceutical, veterinary and diagnostic preparations and substances; custom manufacture of biopharmaceuticals; biomanufacturing for others, namely, processing of biopharmaceutical materials for others; consultancy services relating to manufacturing processes for pharmaceutical, veterinary and diagnostic substances; custom manufacture of recombinant proteins
- Class 042 — Scientific and technological services: Scientific and technological services, namely, pharmaceutical and new product research and design; scientific research and development services; research in the chemical, medical, and/or biochemical field; development of pharmaceutical, veterinary medicine and medical diagnostic substances and products and pharmaceutical research regarding methods for the manufacture thereof, namely, using biotechnological and genetically-engineered means; process development services in relation to pharmaceutical, veterinary and diagnostic substances, namely, consulting regarding the development of pharmaceutical preparations and medicines; technical consultancy in the pharmaceutical, veterinary and diagnostic sector, namely, technical consulting in the field of pharmaceutical studies; new product development services in relation to recombinant protein technology and development
Owner
- GRIFOLS DIAGNOSTIC SOLUTIONS INC., EMERYVILLE, CA, US
- GRIFOLS DIAGNOSTIC SOLUTIONS INC., EMERYVILLE, CA, US
- GRIFOLS DIAGNOSTIC SOLUTIONS INC., EMERYVILLE, CA, US
Prosecution history
- 15 Apr 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 15 Apr 2025 — REGISTERED-PRINCIPAL REGISTER
- 21 Mar 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 21 Mar 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 20 Mar 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 16 Jan 2025 — USE AMENDMENT FILED
- 20 Mar 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 16 Jan 2025 — TEAS STATEMENT OF USE RECEIVED
- 13 Jun 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 May 2024 — SOU EXTENSION 5 GRANTED
- 31 May 2024 — SOU EXTENSION 5 FILED
- 31 May 2024 — SOU TEAS EXTENSION RECEIVED
- 11 Jan 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Jan 2024 — SOU EXTENSION 4 GRANTED
- 09 Jan 2024 — SOU EXTENSION 4 FILED